Urology Doctors in Libertyville, IL Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Dr. Marc Harrison Nelson, Urology Medicare: Accepting Medicare Assignments Practice Location: 1800 Hollister Dr Ste 107, Libertyville, IL 60048 Phone: 847-295-0010    Fax: 847-549-7815

Dr. Kristopher N. Atzeff, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1800 Hollister Dr Ste 107, Libertyville, IL 60048 Phone: 847-295-0010    Fax: 847-549-7815

Dr. Ronald J Kim, M.D Urology Medicare: Accepting Medicare Assignments Practice Location: 1800 Hollister Dr Ste 107, Libertyville, IL 60048 Phone: 847-295-0010    Fax: 847-549-7815

Eric Kirshenbaum, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1800 Hollister Dr Ste 107, Libertyville, IL 60048 Phone: 847-295-0010    Fax: 847-549-7815

Dr. Justin J. Cohen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1800 Hollister Dr Ste 107, Libertyville, IL 60048 Phone: 847-295-0010    Fax: 847-549-7815

News Archive

Final results from ImmuPharma's Phase IIb trial of LUPUZOR

ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.

Factors associated with proteinuria identified

Characteristics associated with proteinuria - a predictor of decline in child kidney function - have been identified, according to a study appearing in the March 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.

New target identified for treatment of idiopathic pulmonary fibrosis

An article published in Experimental Biology and Medicine (Volume 244, Issue 9, June 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219843827) identifies a new target for the treatment of idiopathic pulmonary fibrosis.

Oral sex can trigger bacterial vaginosis

A new study published in the journal PLOS Biology has revealed diverse microbial populations can facilitate vaginal colonization of pathogens, which in turn can prolong the characteristics of bacterial vaginosis, a condition characterized by an imbalance of vaginal microbiome. The study findings also provide evidence linking oral sex with bacterial vaginosis.

Read more Medical News

› Verified 6 days ago